drug summary · 2 NDC codes
LISDEXAMFETAMINE DIMESYLATE 50 mg/1
HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status ANDA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.
Facts
Field definitions, types, and provenance rules are in the data dictionary.
| generic name | LISDEXAMFETAMINE DIMESYLATE |
|---|---|
| active ingredients | LISDEXAMFETAMINE DIMESYLATE |
| dosage form | TABLET, CHEWABLE |
| route | ORAL |
| strength | 50 mg/1 |
| marketing status | ANDA |
| DEA schedule | CII |
| application number | ANDA214134 |
| ATC code | not reported |
| RxCUI | not reported |
| manufacturer | Sun Pharmaceutical Industries, Inc. |
| product type | HUMAN PRESCRIPTION DRUG |
| pharmacologic class | Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE] |
NDC codes
2 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.
| NDC | Package description |
|---|---|
| 57664-087 | — |
| 57664008788 | — |
Other LISDEXAMFETAMINE DIMESYLATE products
25 other products in the current release publish the same generic name. Strength, dosage form, and labeler are what distinguish them.
- LISDEXAMFETAMINE DIMESYLATE 10 mg/1CAPSULE · Sun Pharmaceutical Industries, Inc.
- LISDEXAMFETAMINE DIMESYLATE 10 mg/1TABLET, CHEWABLE · Sun Pharmaceutical Industries, Inc.
- Vyvanse 10 mg/1CAPSULE · Takeda Pharmaceuticals America, Inc.
- Vyvanse 10 mg/1TABLET, CHEWABLE · Takeda Pharmaceuticals America, Inc.
- LISDEXAMFETAMINE DIMESYLATE 20 mg/1TABLET, CHEWABLE · Sun Pharmaceutical Industries, Inc.
- LISDEXAMFETAMINE DIMESYLATE 20 mg/1CAPSULE · Sun Pharmaceutical Industries, Inc.
- Vyvanse 20 mg/1CAPSULE · Takeda Pharmaceuticals America, Inc.
- Vyvanse 20 mg/1TABLET, CHEWABLE · Takeda Pharmaceuticals America, Inc.
- LISDEXAMFETAMINE DIMESYLATE 30 mg/1CAPSULE · Sun Pharmaceutical Industries, Inc.
- LISDEXAMFETAMINE DIMESYLATE 30 mg/1TABLET, CHEWABLE · Sun Pharmaceutical Industries, Inc.
- Vyvanse 30 mg/1CAPSULE · Takeda Pharmaceuticals America, Inc.
- Vyvanse 30 mg/1TABLET, CHEWABLE · Takeda Pharmaceuticals America, Inc.
13 more are listed in the drug product index.
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access to the full catalogue; credited toward the licence.